✦ LIBER ✦

Benzodiazepine receptors and hepatic encephalopathy

✍ Scribed by Roger F. Butterworth; Gilles Pomier Layrargues

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 409 KB
Volume: 11
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840110323

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benzodiazepine-receptor ligands and hepa

Benzodiazepine-receptor ligands and hepatic encephalopathy: A causal relationship?

✍ Jeffrey D. Rothstein 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB 👁 1 views

Benzodiazepines are a class of heterocyclic compounds typically represented by the antianxiety drug diazepam. About 15 years ago, a high-affinity binding site for benzodiazepines was discovered in brain tissue, and it appeared that this receptor was in some way part of the receptor complex for the i

Increased endogenous neuropeptide ligand

Increased endogenous neuropeptide ligand for benzodiazepine receptors in hepatic encephalopathy

✍ Roger F. Butterworth 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 1 views

The involvement of benzodiazepine recept

The involvement of benzodiazepine receptor ligands in hepatic encephalopathy

✍ Anthony S. Basile; E. Anthony Jones; Peter Widler; Hans U. Fisch; Thomas Schläep 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

Detection of benzodiazepine in hepatic e

Detection of benzodiazepine in hepatic encephalopathy

✍ Kevin D. Mullen; Roger F. Butterworth; John Wells; Gilles Pomier-Layrargues 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 1 views

Cerebral benzodiazepine receptor binding

Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy

✍ G A Macdonald; K A Frey; B W Agranoff; S Minoshima; R A Koeppe; D E Kuhl; B L Sh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 1 views

Increased activation of the central benzodiazepine receptor (BZR) appears to play an important role in hepatic encephalopathy (HE). However, there is controversy regarding whether the density or affinity of BZRs is altered. A previous positron emission tomography (PET) study using the BZR antagonist

Flumazenil and hepatic encephalopathy

✍ Olavo B. Amaral; João Quevedo; Roger Walz; Flávio Kapczinski 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

We read with interest the article recently published in HEPATOLOGY, 1 which suggested that heterozygosity for hemochromatosis C282Y mutation could be associated with more fibrosis in patients with chronic active hepatitis (CAH) owing to hepatitis C virus (HCV). Liver iron accumulation has been obser